ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1981

The Association Between X-ray Progression and Clinical Outcomes in Patients with Hand Osteoarthritis with 5-year Follow-up

Olga Sleglova1, Jiri Baloun2, Jindriska Gatterova1, Xiao Svec1, Olga Ruzickova1, Karel Pavelka3 and Ladislav Senolt4, 1Rheumatology Institute, Prague, Czech Republic, 2Institute of Rheumatology, Prague, Czech Republic, 3Institut of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Praha, Czech Republic, 4Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Praha, Czech Republic

Meeting: ACR Convergence 2023

Keywords: hand, Health Assessment Questionnaire (HAQ), Osteoarthritis, pain, X-ray

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1977–1995) Osteoarthritis – Clinical Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Hand osteoarthritis (HOA) is a heterogeneous disorder with two main subtypes, non-erosive and erosive. The progression of HOA is assessed by various radiographic scoring methods, including the Kallmann scale, and the understanding of the association between radiographic changes and clinical symptoms might help improve the monitoring of disease progression.This study aimed to investigate the association of the Kallman scale with clinical assessment parameters and the erosive subtype in a Czech population of HOA patients over 5 years.

Methods: Consecutive patients with symptomatic HOA fulfilling the American College of Rheumatology (ACR) criteria were included in this study. All patients were evaluated at baseline and follow-up examinations over 2 and 5 years. Clinical examinations were performed by qualified rheumatologists. The number of clinically tender and swollen joints was recorded. Pain, stiffness, and function were assessed. Hand disability was evaluated based on the Algofunctional index. The visual analog scale (VAS-pain) and the health assessment questionnaire (HAQ) was used for the assessment of pain and function/disability. Postero-anterior plain radiographs of both hands were examined, and radiographs were scored by two trained readers (rheumatologists) according to the Kallman scale.

Results: Of 154 patients enrolled in this study, 129 subjects (89.3% females; mean age at baseline = 64.6±8.0 years) met the ACR classification criteria for HOA and were followed up over 5 years at the outpatient department of the Institute of Rheumatology in Prague. Out of these patients, 57 were diagnosed with the non-erosive form (87.7% females; mean age at baseline = 63.8±7.7 years) and 72 with the erosive form (90.3% females; mean age at baseline = 65.7±8.1 years), where erosive HOA was defined by at least one interphalangeal joint with radiographic signs of erosion. Firstly, we analyzed each examination separately and found that the Kallman scale was both significantly increased in patients with the erosive subtype (2.95 – 3.12-fold, p< 0.001 for all) and associated with age in all examinations (β = 1.27 – 1.57; p< 0.001 for all). Next, we used generalized additive modeling (GAM) to analyze data collected over five years and discovered the association of the scale with HOA subtypes and age (p < 0.01 for both). GAM also revealed associations of the Kallman scale with HAQ (edf=2.5, p=0.016) in all patients and patients with non-erosive HOA (edf=1.7, p=0.027). Similarly, the scale was associated with the number of clinically swollen joints in all HOA patients (edf = 1, p = 0.041) and patients with non-erosive HOA (edf=4, p=0.046). Eventually, the Algofunctionalindex (edf=1.9, p=0.02) was only associated with the scale in all HOA patients. Other parameters (e.g., AUSCANs) were insignificant.

Conclusion: Our 5-year longitudinal study revealed the associations of structural progressions with both subtypes and age at each time point. In contrast, functional impairments were only associated with progression in the non-erosive subset and all HOA patients. Further studies in a larger cohort of patients are needed to validate these data.

Acknowledgments: This work was supported by MHCR 023728 and AZV No. 18-00542.

Supporting image 1

Associations of the Kallman scale with the Algofunctional index, HAQ, and the number of clinically swollen joints in patients with erosive and non-erosive HOA.


Disclosures: O. Sleglova: None; J. Baloun: None; J. Gatterova: None; X. Svec: None; O. Ruzickova: None; K. Pavelka: Abbvie, 2, 6, Amgen, 2, 6, Bristol-Myers Squibb(BMS), 2, 6, Egis, 2, 6, MSD, 2, 6, Pfizer, 2, 6, Roche, 2, 6, UCB, 2, 6; L. Senolt: None.

To cite this abstract in AMA style:

Sleglova O, Baloun J, Gatterova J, Svec X, Ruzickova O, Pavelka K, Senolt L. The Association Between X-ray Progression and Clinical Outcomes in Patients with Hand Osteoarthritis with 5-year Follow-up [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/the-association-between-x-ray-progression-and-clinical-outcomes-in-patients-with-hand-osteoarthritis-with-5-year-follow-up/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-association-between-x-ray-progression-and-clinical-outcomes-in-patients-with-hand-osteoarthritis-with-5-year-follow-up/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology